Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Radiofrequency Ablation Combined With Systematic Neoadjuvant Therapy in the Treatment of Recurrent Hepatocellular Carcinoma

NCT05277675 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.

NCT NCT05277675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05277675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Radiofrequency Ablation Combined With Systematic Neoadjuvant Therapy in the Treatment of Recurrent Hepatocellular Carcinoma
Lead sponsor
Southwest Hospital, China
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2021
Completion date
October 30, 2023
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma recurrent